Wipfli Financial Advisors’s Gilead Sciences GILD Stock Holding History

Wipfli Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$593K	Buy	+9,618	New	+$606K	0.04%	189

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wipfli Financial Advisors's GILD Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Gilead Sciences (GILD) in Q3 2022: 9,618 shares worth $593K. The stake represents 0.04% of the portfolio and ranks #189 among its holdings.

1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

Wipfli Financial Advisors held 9,618 shares of Gilead Sciences worth $593K as of Q3 2022.
Gilead Sciences was a new Wipfli Financial Advisors position in Q3 2022.
Gilead Sciences made up 0.04% of Wipfli Financial Advisors's portfolio in Q3 2022, its #189 holding.
1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.